BFM
AGIO icon

Boothbay Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History

Boothbay Fund Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.56M Buy
+149,886
New +$4.55M 0.07% 317
2026
Q1 		– Sell
-37,291
Closed -$1.06M – 2021
2025
Q4 		$1.02M Sell
37,291
-458,050
-92% -$16.1M 0.02% 793
2025
Q3 		$19.9M Buy
495,341
+48,322
+11% +$1.82M 0.29% 52
2025
Q2 		$14.9M Buy
447,019
+185,798
+71% +$5.63M 0.29% 63
2025
Q1 		$7.65M Buy
261,221
+9,447
+4% +$313K 0.2% 129
2024
Q4 		$8.27M Buy
251,774
+18,718
+8% +$879K 0.2% 137
2024
Q3 		$10.4M Buy
233,056
+9,077
+4% +$412K 0.24% 88
2024
Q2 		$9.66M Sell
223,979
-45,000
-17% -$1.62M 0.23% 75
2024
Q1 		$7.86M Sell
268,979
-17,466
-6% -$468K 0.15% 113
2023
Q4 		$6.38M Buy
+286,445
New +$6.42M 0.16% 138
2022
Q3 		– Sell
-539,006
Closed -$11.9M – 2205
2022
Q2 		$11.9M Buy
539,006
+432,672
+407% +$9.77M 0.31% 32
2022
Q1 		$3.1M Buy
+106,334
New +$3.25M 0.07% 383
2021
Q3 		– Sell
-9,517
Closed -$524K – 1864
2021
Q2 		$524K Sell
9,517
-2,241
-19% -$125K 0.02% 980
2021
Q1 		$607K Buy
+11,758
New +$582K 0.02% 841

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Boothbay Fund Management's AGIO Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 149,886 shares worth $5.56M. The stake represents 0.07% of the portfolio and ranks #317 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in AGIO as recently as Q4 2025.

Boothbay Fund Management first reported a position in AGIO in Q1 2021 and has held it in 14 quarters since. The position peaked at $19.9M in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Boothbay Fund Management held 149,886 shares of Agios Pharmaceuticals worth $5.56M as of Q2 2026.
  • Agios Pharmaceuticals was a new Boothbay Fund Management position in Q2 2026.
  • Agios Pharmaceuticals made up 0.07% of Boothbay Fund Management's portfolio in Q2 2026, its #317 holding.
  • Boothbay Fund Management first reported a position in Agios Pharmaceuticals in Q1 2021 and has held it in 14 quarters since.
  • Boothbay Fund Management's Agios Pharmaceuticals position peaked at $19.9M in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.